Turkkahraman, D. Et Al. 2008. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: Initial response to oral sulphonylurea therapy. JOURNAL OF PEDIATRICS , vol.153, no.1 , 122-126.

Turkkahraman, D., Brcan, I., Tribble, N. D., Akcurin, S., Ellard, S., & Gloyn, A. L., (2008). Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: Initial response to oral sulphonylurea therapy. JOURNAL OF PEDIATRICS , vol.153, no.1, 122-126.

Turkkahraman, Doga Et Al. "Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: Initial response to oral sulphonylurea therapy," JOURNAL OF PEDIATRICS , vol.153, no.1, 122-126, 2008

Turkkahraman, Doga Et Al. "Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: Initial response to oral sulphonylurea therapy." JOURNAL OF PEDIATRICS , vol.153, no.1, pp.122-126, 2008

Turkkahraman, D. Et Al. (2008) . "Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: Initial response to oral sulphonylurea therapy." JOURNAL OF PEDIATRICS , vol.153, no.1, pp.122-126.

@article{article, author={Doga Turkkahraman Et Al. }, title={Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: Initial response to oral sulphonylurea therapy}, journal={JOURNAL OF PEDIATRICS}, year=2008, pages={122-126} }